Cargando…
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study
BACKGROUND: Vulnerable dialysis and kidney transplant patients show impaired seroconversion rates compared to medical personnel eight weeks after SARS-CoV-2mRNA vaccination. METHODS: We evaluated six months follow up data in our observational Dia-Vacc study exploring specific cellular (interferon-γ...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995854/ https://www.ncbi.nlm.nih.gov/pubmed/35434688 http://dx.doi.org/10.1016/j.lanepe.2022.100371 |